Authors: Shen S et al.
Anesthesiology Open 1(1): e0005 10.1097/ao9.0000000000000005
Summary
This editorial comments on the Delaporte et al. retrospective cohort study examining intraoperative hypotension and delayed graft function (DGF) after kidney transplantation. Shen and Shaw emphasize that the association between hypotension burden and DGF is biologically plausible, clinically meaningful, and difficult to ignore.
Delaporte et al. demonstrated a dose–response relationship between cumulative intraoperative hypotension—quantified as area under the curve (AUC) for mean arterial pressure (MAP) <65 mmHg—and delayed graft function. Each additional 50 mmHg·min spent below MAP 65 mmHg was associated with an 8% increase in odds of DGF. The editorial reinforces this central message succinctly: new kidneys do not tolerate hypotension.
The authors highlight several key physiologic considerations:
-
Transplanted kidneys arrive with ischemia–reperfusion injury, endothelial dysfunction, microvascular congestion, and impaired autoregulation.
-
Hypotension that might be tolerated in nontransplant surgery may represent direct ischemic injury in a newly implanted graft.
-
Deceased-donor kidneys showed a stronger association between hypotension and DGF than living-donor kidneys, suggesting graft vulnerability is modified by organ quality and ischemic burden.
They also raise important unanswered questions:
-
Is increasing MAP equivalent to improving graft perfusion? Vasopressors restore pressure, but not necessarily microvascular flow.
-
Could high-dose α-agonists worsen renal microcirculatory oxygen delivery despite normal systemic MAP?
-
How does preoperative dialysis timing and intravascular volume status interact with intraoperative hypotension risk?
The authors call for transplant-specific prospective trials to define optimal MAP targets and clarify phase-specific hemodynamic management (pre- vs post-reperfusion). They also suggest that graft injury may not be the only outcome affected; hypotension may impact broader multiorgan morbidity in this high-risk population.
Key Points
-
Hypotension burden (depth + duration) is strongly associated with delayed graft function.
-
Deceased-donor grafts appear more vulnerable to perfusion deficits.
-
Transplanted kidneys likely have impaired autoregulation and heightened sensitivity to perfusion pressure changes.
-
Maintaining adequate MAP is one of the few modifiable intraoperative variables in transplant care.
-
Prospective, transplant-specific hemodynamic trials are urgently needed.
What You Should Know
This editorial reframes hypotension in kidney transplantation from a generic anesthesia metric to a graft-specific injury driver.
While traditional MAP thresholds (e.g., 65 mmHg) are widely accepted in nontransplant populations, this piece challenges whether that threshold is sufficient for reperfused, ischemia-primed renal grafts, particularly from deceased donors.
For transplant anesthesiology, the take-home message is pragmatic:
Blood pressure management during kidney transplantation should be deliberate and transplant-specific, not generic.
In a clinical arena where donor quality and immunologic risk are largely unmodifiable, intraoperative hemodynamics may represent one of the few controllable levers influencing early graft survival.
Thank you to Anesthesiology Open for allowing us to summarize and share this editorial.